AN-260

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAN-260
Drug Alias NameAN-260
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsHeart FailureArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInotek Pharmaceuticals CorporationRocket Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInotek Pharmaceuticals Corporation
Inactive CompaniesN/A
Active IndicationsHeart FailureArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A